metricas
covid
Buscar en
Revista de Psiquiatría y Salud Mental (English Edition)
Toda la web
Inicio Revista de Psiquiatría y Salud Mental (English Edition) Validity of the PANSS cognitive factor as a measurement of cognitive performance...
Journal Information
Vol. 2. Issue 4.
Pages 160-168 (January 2009)
Share
Share
Download PDF
More article options
Vol. 2. Issue 4.
Pages 160-168 (January 2009)
Original
Full text access
Validity of the PANSS cognitive factor as a measurement of cognitive performance in schizophrenia
Validez del factor cognitive de la PANSS como medida del rendimiento cognitive en esquizofrenia
Visits
1418
David Gil
Corresponding author
crpsantpsico1@mennisant.com

Corresponding author.
, Rosario Bengochea, Marta Arrieta, Mar Fernández, Ana Álvarez, Raúl Sánchez, Raquel Prat, Alexandra Arce
Padre Menni Psychosocial Rehabilitation Centre, Santander, Cantabria, Spain
This item has received
Article information
Abstract
Introduction

The Positive and Negative Syndrome Scale (PANSS) is a widely used instrument for measuring symptomatology in patients with schizophrenia. Numerous studies have analyzed the factorial structure of this scale and have suggested a five factor model, namely: negative, positive, excited, anxiety/depression, and disorganized (or cognitive). The latter factor has been related to neuropsychological tests, with a view to analyzing its utility as a measure of cognitive functioning in schizophrenia, but data are inconclusive. The aim of the present study was to analyze the factorial structure of the PANSS and to assess the relationships between factors and neurocognitive tests.

Material and methods

The sample comprised 235 outpatients diagnosed with schizophrenia. To investigate the factorial structure of the PANSS, a principal component factor analysis was performed. Cognitive functioning was measured with a shortened version of the Barcelona Test.

Results

Unlike previous studies, our study obtained a six-factor model, with disorganized and cognitive symptoms separated in two different factors. The cognitive factor obtained in this study was related to all subtests of the Barcelona Test. The disorganized factor, however, was only related to two of these subtests.

Conclusions

Our results support the use of a six-factor model and suggest that the cognitive factor could be a valid measure of cognitive deficits in schizophrenia, although the use of a standard neuropsychological battery is advisable.

Keywords:
PANSS
Schizophrenia
Cognitive factor
Cognitive deficits
Resumen
Introducción

La Escala de los Síndromes Positivo y Negativo (PANSS) es uno de los instrumentos más utilizados para valorar la sintomatología de los pacientes con esquizofrenia. Numerosos estudios han analizado la estructura factorial de esta escala, y han propuesto la existencia de cinco factores: negativo, positivo, excitación, ansiedad/depresión y desorganización (o cognitivo). Este último factor se ha relacionado con pruebas neuropsicológicas con la finalidad de analizar su utilidad como medida del rendimiento cognitivo en esquizofrenia, aunque no se han obtenido resultados concluyentes. El objetivo del presente estudio es analizar la estructura de la PANSS y relacionar los factores obtenidos con pruebas cognitivas.

Material y métodos

La muestra del estudio está compuesta por 235 pacientes, diagnosticados de esquizofrenia, que viven en la comunidad. La estructura de la PANSS se valoró mediante un análisis factorial de componentes principales. Para evaluar el rendimiento cognitivo se utilizó una versión reducida del Test Barcelona.

Resultados

A diferencia de estudios previos, se obtuvieron seis factores principales, ya que se separó el factor desorganización/cognitivo en dos factores distintos. El factor cognitivo obtenido en el estudio correlacionó con todos los subtests del Test Barcelona, mientras que el factor desorganización sólo lo hizo con dos de esos subtests.

Conclusiones

Los resultados obtenidos recomiendan utilizar un modelo factorial de seis factores, e indican que el factor cognitivo de la PANSS puede usarse como medida del rendimiento cognitivo en esquizofrenia, si bien es aconsejable realizar una evaluación neuropsicológica más amplia.

Palabras clave:
PANSS
Esquizofrenia
Factor cognitivo
Déficit cognitivos
Full text is only aviable in PDF
References
[1.]
S.R. Kay, A. Fisbein, L.A. Opler.
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Schizophr Bull, 13 (1987), pp. 261-276
[2.]
V. Peralta, M.J. Cuesta.
Psychometric properties of the positive and negative syndrome scale (PANSS) in schizophrenia.
Psychiatry Res, 53 (1994), pp. 31-40
[3.]
S.R. Kay, S. Sevy.
Pyramidal model of schizophrenia.
Schizophr Bull, 16 (1990), pp. 537-545
[4.]
L. White, P.D. Harvey, L. Opler, J.P. Lindenmayer, The PANSS Study Group.
Empirical assessment of the factorial structure of clinical symptoms in schizophrenia.
Psychopathology, 30 (1997), pp. 263-274
[5.]
S.R. Kay, L.A. Opler, A. Fiszbein.
Positive and Negative Syndrome Scale (PANSS).
Multi-Health Systems, (2000),
[6.]
P.B. Fitzgerald, A. De Castella, K. Brewer, K. Filia, J. Collins, P. Davey, et al.
A confirmatory factor analytic evaluation of the pentagonal PANSS model.
Schizophr Res, 61 (2003), pp. 97-104
[7.]
M.D. Bell, P.H. Lysaker, R.M. Milstein, J.L. Beam-Goulet.
Concurrent validity of the cognitive component of schizophrenia: relationship of PANSS scores to neuropsychological assessments.
Psychiatry Res, 54 (1994), pp. 51-58
[8.]
J.P. Lindenmayer, S. Grochowski, R.B. Hyman.
Five factor model of schizophrenia: replication across samples.
Schizopr Res, 14 (1995), pp. 229-234
[9.]
S.R. Marder, J.M. Davis, G. Chouinard.
The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American Trials.
J Clin Psychiatry, 58 (1997), pp. 538-546
[10.]
C. Lançon, V. Aghabian, P. Llorca, P. Auquier.
Factorial structure of the Positive and Negative Syndrome Scale (PANSS): a forced five-dimensions factor analysis.
Acta Psychiatr Scandinav, 98 (1998), pp. 369-376
[11.]
C. Lançon, P. Auquier, G. Nayt, G. Reine.
Stability of the five factor structure of the Positive and Negative Syndrome Scale (PANSS).
Schizophr Res, 42 (2000), pp. 231-239
[12.]
L. Lykouras, P. Oulis, K. Psarros, E. Dasklopoulou, A. Botsis, G.N. Christodoulou, et al.
Five-factor model of schizophrenia pathology: how valid is it?.
Eur Arch Psychiatry Clin Neurosci, 250 (2000), pp. 93-100
[13.]
R. Mass, T. Schoemig, K. Hitschfeld, E. Wall, C. Haasen.
Psychopathological syndromes of schizophrenia: evaluation on the dimensional structure of the Positive and Negative Syndrome Scale.
Schizophr Bull, 26 (2000), pp. 167-177
[14.]
J.E.D. Wolthaus, P.M.A.J. Dingemans, A.H. Schene, D.H. Linszen, H. Knegtering, E.A.E. Holthausen, et al.
Component structure of the Positive and Negative Syndrome Scale (PANSS) in patients with recent-onset schizophrenia and spectrum disorders.
Psychopharmacology, 150 (2000), pp. 399-403
[15.]
D. Whitehorn, J. Brown, J. Richard, Q. Rui, L. Kopala.
Multiple dimensions of recovery in early psychosis.
Int Rev Psychiatry, 14 (2002), pp. 273-283
[16.]
R. Emsley, J. Rabinowitz, M. Torreman, The RIS-INT-35 Early Psychosis Blobal Working Group.
The factor structure for the Positive and Negative Syndrome Scale (PANSS) in recent-onset psychosis.
Schizophr Res, 61 (2003), pp. 47-57
[17.]
K.P. Good, J. Rabinowitz, D. Whitehorn, P.D. Harvey, G. DeSmedt, L.C. Kopala.
The relationship of neuropsychological test performance with the PANSS in antipsychotic naïve, firstepisode psychosis patients.
Schizophr Res, 68 (2004), pp. 11-19
[18.]
S. Klingberg, A. Wittorf, G. Wiedemann.
Disorganization and cognitive impairment in schizophrenia: independent symptom dimensions?.
Eur Arch Psychiatry Clin Neurosci, 256 (2006), pp. 532-540
[19.]
M. Van der Gaag, A. Cuijpers, T. Hoffman, M. Remijsen, R. Hijman, L. De Haan, et al.
The five-factor model of the Positive and Negative Syndrome Scale I: Confirmatory factor analysis fails to confirm 25 published five-factors solutions.
Schizophr Res, 85 (2006), pp. 273-279
[20.]
M. Van der Gaag, T. Hoffman, M. Remijsen, R. Hijman, L. De Haan, B. Van Meijel, et al.
The five-factor model of the Positive and Negative Syndrome Scale II: A ten-fold cross-validation of a revised model.
Schizophr Res, 85 (2006), pp. 280-287
[21.]
G. Bryson, M. Bell, T. Greig, E. Kaplan.
Internal consistency, temporal stability and neuropsychological correlates of three cognitive components of the Positive and Negative Syndrome Scale (PANSS).
Schizophr Res, 38 (1999), pp. 27-35
[22.]
E. González Pablos, L. Minués Martín, F. Alonso del Teso, R. Sanguino Andrés.
La función cognitiva en la esquizofrenia a través del componente cognitivo de la PANSS.
Anales de Psiquiatría, 21 (2005), pp. 274-279
[23.]
P.D. Harvey, M.R. Serper, L. White, M.J. Parrella, S.R. McGurk, P.J. Moriarty, et al.
The convergence of neuropsychological testing and clinical ratings of cognitive impairment in patients with schizophrenia.
Compr Psychiatry, 42 (2001), pp. 306-313
[24.]
T.S. Ehmann, I. Khanbhai, G.W. Macewan, G.N. Smith, W.G. Honer, S. Flynn, et al.
Neuropsychological correlates of the PANSS cognitive factor.
Psychopathology, 37 (2004), pp. 253-258
[25.]
A. Hofer, B. Niedermayer, G. Kemmler, M.A. Rettenbacher, E. Trebo, C.G. Widschwendter, et al.
Cognitive impairment in schizophrenia: clinical ratings are not a suitable alternative to neuropsychological testing.
Schizophr Res, 92 (2007), pp. 126-131
[26.]
J. Peña-Casanova.
Test Barcelona. Manual.
Masson, (1990),
[27.]
J. Peña-Casanova, Normalidad.
semiología y patología neuropsicológicas.
Masson, (1991),
[28.]
D. Gil, R. Bengochea, M. Arrieta, I. Lastra, R. Sánchez, A. Alvarez, et al.
Uso del Test Barcelona para la valoración cognitiva de los pacientes con esquizofrenia.
Actas Esp Psiquiatr, 36 (2008), pp. 337-344
[29.]
C. Mongay.
Quimiometría.
Universitat de València, (2005),
[30.]
A.M. Brickman, M.S. Buchsbaum, R. Bloom, P. Bokhoven, R. Paul-Odouard, M.M. Haznedar, et al.
Neuropsychological functioning in first-break, never medicated adolescents with psychosis.
J Nerv Ment Dis, 192 (2004), pp. 615-622
[31.]
R.S. Keefe, R.M. Bilder, P.D. Harvey, S.M. Davis, B.W. Palmer, J. Gold, et al.
Baseline neurocognitive deficits in the CATIE schizophrenia trial.
Neuropsychopharmacology, 31 (2006), pp. 2033-2046
[32.]
C. Hughes, V. Kumari, W. Soni, M. Das, B. Binneman, S. Drozd, et al.
Longitudinal study of symptoms and cognitive function in chronic schziophrenia.
Schizophr Res, 59 (2003), pp. 137-146
[33.]
R. Krisnadas, B. Moore, A. Nayak, R. Patel.
Relationship of cognitive function in patients with schizophrenia in remission to disability: a cross-sectional study in a Indian sample.
Ann Gen Psychiatry, 6 (2007), pp. 19
[34.]
P. Brazo, P. Delamillieure, R. Morello, I. Halbecq, R.M. Marié, S. Dollfus.
Impairments of executive/attentional functions in schizophrenia with primary and secondary negative symptoms.
Psychiatry Res, 133 (2005), pp. 45-55
[35.]
R.M. Bilder, R.S. Goldman, D. Robinson, G. Reiter, L. Bell, J.A. Bates, et al.
Neuropsychology of firt-episode schizophrenia: initial characterization and clinical correlates.
Am J Psychiatry, 157 (2000), pp. 549-559
[36.]
R. Halari, R. Mehrotra, T. Sharma, V. Kumasi.
Does self-perceived mood predict more variante in cognitive performance than clinician-related symptoms in schizophrenia?.
Schizophr Bull, 32 (2006), pp. 751-756
[37.]
A.J. Van der Voes, P.M. Dingemans, D.H. Linszen, M.A. Nugter, W.F. Scholte.
Symptoms, cognitive and social functioning in recent-onset schizophrenia: a longitudinal study.
Schziophr Res, 19 (1996), pp. 61-71
[38.]
G. Brebion, M.J. Smith, X. Amador, D. Malaspina, J.M. Gorman.
Clinical correlates of memory in schizophrenia: differential links between depression, positive and negative symptoms, and two types of memory impairment.
Am J Psychiatry, 154 (1997), pp. 1538-1543
[39.]
V.P. Bozikas, M.H. Kosmidis, K. Kioperlidou, A. Karavatos.
Relationship between psychopathology and cognitive functioning in schizophrenia.
Compr Psychiatry, 245 (2000), pp. 392-400
Copyright © 2009. SEP y SEPB
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos